Application of antibiotic substitute drug melatonin in resisting infection of meningitis escherichia coli pathogens on child patients

A technology that replaces antibiotics and Escherichia coli, and is applied in the direction of resistance to vector-borne diseases, antibacterial drugs, and drug combinations. Achieve the effect of reducing expression and invasion of inflammatory cells, reducing expression and invasion of inflammatory cells, and reducing damage

Active Publication Date: 2019-08-23
YANGZHOU UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are mainly the following problems in the prevention of meningitis: the blood-brain barrier of newborns is not fully developed, so pathogenic bacteria will invade the brain, and it is necessary to find drugs that can promote the development of the blood-brain barrier and have a preventive effect; a large number or excessive use of antibiotics will It leads to the confusion of the intestinal flora of the body, the decline of the body's metabolism and immunity, and the emergence of bacterial drug resistance; therefore, it is very important to find more effective drugs to replace antibiotics
However, the protective effect of melatonin instead of antibiotics in preventing meningitis in mice infected with APEC XM-TW has not been reported, and the prevention of meningitis in mice by regulating intestinal microbes has not been reported, so this study is innovative Innovative, advanced and applicable, providing new ideas and technical means for the prevention of meningitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of antibiotic substitute drug melatonin in resisting infection of meningitis escherichia coli pathogens on child patients
  • Application of antibiotic substitute drug melatonin in resisting infection of meningitis escherichia coli pathogens on child patients
  • Application of antibiotic substitute drug melatonin in resisting infection of meningitis escherichia coli pathogens on child patients

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] 1. Main drugs and reagents

[0045] Melatonin (melatonin, MT) was purchased from Sigma, USA; formalin, PBS, DAB reagent, hematoxylin, eosin, distilled water. Tryptone (Tryptone) and yeast extract (Yeast extract) were purchased from Oxoid Company; sodium chloride (NaCl), diamine hydrogen citrate (C 6 h 14 N 2 o 7 ), sodium acetate (CH 3 COONa), dipotassium hydrogen phosphate (K 2 HPO 4 ), magnesium sulfate (MgSO 4 ), manganese sulfate (MnSO 4 ) and other analytical reagents were purchased from Sinopharm Chemical Reagent Co., Ltd.; MacConkey agar was purchased from Haibo Company; , glucose (Glucose) were purchased from Sigma Company; Faststart Universal SYBR GREEN Master (ROX) Fluorescence Quantitative Kit was purchased from Roche Company; Reagents are domestic analytical grade reagents.

[0046] 2. Main instruments

[0047] Ultra-clean workbench was purchased from Suzhou Purification Equipment Co., Ltd.; fluorescent quantitative PCR7500 was purchased from ABI ...

Embodiment 2

[0082] (1) Preparation of APEC TW-XM strain

[0083] First recover the bacteria from the seed preservation tube, line the four zones on the LB solid plate, and culture overnight in a 37°C incubator. The next day, pick a single colony and culture it in the liquid LB medium for 16 hours, and then follow the ratio of bacteria and medium 1:100 Transfer the bacterial solution to the liquid LB medium and cultivate to OD 600 When =1, collect the bacterial liquid, wash the bacterial suspension twice with PBS, resuspend it with normal saline, and dilute it to cfu=10 7 , for mouse infection.

[0084] (2) Experiment of melatonin preventing the onset of meningitis in mice

[0085] The mice were randomly divided into four groups, 6 in the (NS) group, 6 in the melatonin (MT) group, and 26 in the APEC TW-XM (A) group (10-bacteria counting, 6-pathological sections, 10 for Statistical survival rate), APEC TW-XM+melatonin (A+MT) group 26 (10-bacteria count, 6-pathological section, 10 for sta...

Embodiment 3

[0104] (1) Preparation of APEC TW-XM strain

[0105] With embodiment 2.

[0106] (2) Melatonin regulates intestinal flora to prevent meningitis

[0107] The mice were randomly divided into four groups, APEC TW-XM group: daily intraperitoneal injection of 100 μl of normal saline; daily replacement of sterile water; A+MT group: daily intraperitoneal injection of 100 μl of 30 mg / kg MT; daily replacement of sterile water; Group A+antibiotics: intraperitoneally inject 100 μl of normal saline every day; replace sterile water containing antibiotics every day; A+antibiotics+MT: inject 100 μl 30 mg / kg MT intraperitoneally every day; replace sterile water containing antibiotics every day; 8 days for challenge (cfu=10 7 ) to collect samples.

[0108] (3) Sample collection

[0109] Permeability detection (EB staining): Same as Example 1.

[0110] Detection of inflammatory factors: same as Example 1.

[0111] The making of pathological section: with embodiment 2.

[0112] Notes to t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides application of an antibiotic substitute drug melatonin in preventing the infection of meningitis escherichia coli pathogens on child patients. Meningitis-type escherichia coli is separated and identified from muscovy duck cerebrospinal fluid, a meningitis model of 3-week-old ICR mice is constructed for the first time by utilizing the strain, and the successful construction of the mouse meningitis model is evaluated from the aspects of neurological symptom scoring, mortality difference statistics, the damage degree of a blood-brain barrier, expression of meningitis-related inflammatory factors and the like respectively. With antibiotics as references, the mice are treated with the melatonin and the four combined antibiotics respectively, one week later, the disease onset conditions of the meningitis mice are detected, results show that through the melatonin and the combined use of the antibiotics, the neurological symptoms of the meningitis mice can both be reduced, the survival rate of the meningitis mice is increased, integrity keeping of the blood-brain barrier is promoted by the melatonin, the invasion of inflammatory cells into the central nervous systemis reduced, the disease onset of the meningitis in the mice is prevented through the function of the brain-gut axis, and a new antibiotic substitute and treatment strategy are provided for preventingneonatal meningitis diseases.

Description

technical field [0001] The invention relates to the application of melatonin (melatonin), a medicine replacing antibiotics, to resist meningitis Escherichia coli pathogenic infection in children. The present invention further provides a drug for replacing antibiotics to prevent the onset of meningitis and its application characteristics, which is expected to provide a new strategy for preventing the onset of meningitis. Background technique [0002] Since Vieusseux first reported bacterial meningitis (BM) in 1806, it has been considered as an important fatal disease, and it is an infection of the central nervous system that is of great clinical concern in humans and animals. There are many pathogenic bacteria that cause bacterial meningitis, among which the mortality rate of neonatal meningitis caused by Escherichia coli ranks among the highest in the world. Meningitis Escherichia coli mainly include neonatal meningitis Escherichia coli (NMEC) and avian meningitis Escherich...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4045A61P25/00A61P31/04A01K67/02
CPCA61K31/4045A61P25/00A61P31/04A01K67/02A01K2227/105A01K2267/03Y02A50/30
Inventor 武琥琮刘家奇朱国强张东夏芃芃任文凯
Owner YANGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap